Rational Design, Synthesis, and In Vitro Activity of Heterocyclic Gamma-Butyrobetaines as Potential Carnitine Acetyltransferase Inhibitors. [PDF]
Stoyanova S, Bogdanov MG.
europepmc +1 more source
Changes in the Metabolome of Different Tissues in Response to Streptozotocin Diabetes and Mildronate Exposure: A Metabolomic Assessment. [PDF]
Hauton D +4 more
europepmc +1 more source
Kynurenine Pathway Metabolites as Mediators of Exercise-Induced Mood Enhancement, Fatigue Resistance, and Neuroprotection. [PDF]
Tero-Vescan A +5 more
europepmc +1 more source
Doping scandals, Rio and the future of human enhancement [PDF]
Savulescu, Julian
core +2 more sources
<b>Gut‒heart axis: emerging therapies targeting trimethylamine</b> <b>N-oxide production</b>. [PDF]
Torres ER, Wilcox J, Tang WHW.
europepmc +1 more source
Annual Banned-Substance Review 18th Edition-Analytical Approaches in Human Sports Drug Testing 2024/2025. [PDF]
Thevis M, Kuuranne T, Geyer H.
europepmc +1 more source
A review on fueling recovery: the role of metabolic modulation in non-obstructive myocardial stunning. [PDF]
Özkan U +4 more
europepmc +1 more source
Rational Design, Synthesis and In Vitro Activity of Diastereomeric <i>Cis</i>-/<i>Trans</i>-3-Substituted-3,4-Dihydroisocoumarin-4-Carboxylic Acids as Potential Carnitine Acetyltransferase Inhibitors. [PDF]
Stoyanova S, Bogdanov MG.
europepmc +1 more source
Molecular and Biochemical Mechanisms of Cardiomyopathy Development Following Prenatal Hypoxia-Focus on the NO System. [PDF]
Popazova O +6 more
europepmc +1 more source
Mammalian hydroxylation of microbiome-derived obesogen, delta-valerobetaine, to homocarnitine, a 5-carbon carnitine analog. [PDF]
Weinberg J +13 more
europepmc +1 more source

